What to make of this tumor response rate of ONLY 11%?
a reasonable starting point is in the article title where it specifically states it is a study of RECURRENT cervical cancer patients, which means these patients have essentially failed standard therapy. in general, the prognosis of recurrent cervical cancer is poor. run out of luck. book trips to visit that 100 places. doctors shrug shoulders and say sorry.
with this group of 110 patients with cervical ca recurrence thus poor prognosis --hopeless and helpless in laymen's term--adxs vaccine did this:
47 out of the 110 patients have their disease controlled and stabilized. that is close to 1 out of 2.
of interest is the subset of 6 patients with partial tumor response, and another 6 with COMPLETE tumor response. (6 + 6 out of 110 is 11%)
the adxs vaccine is one heck of a life prolonging option when all else failed!
Worth noting too, is that the success is about equal to cisplatin treatment with significantly less side effects.
I went through a heavy cisplatin treatment along with a couple of other chemo drugs and the cisplatin infusions are vividly miserable experiences!